1-7 of 7
Long Chang
Close
Sort by
Journal Articles

Adult Langerhans Cell Histiocytosis with Liver Involvement

Long Chang, Lin He, Huacong Cai, Minghui Duan, Jian Li, Daobin Zhou, Gaurav Goyal, Xinxin Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 3197.
https://doi.org/10.1182/blood-2023-184790
Published: 2023
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Huixing Zhou, Long Chang, Jing Jia, Jie Ma, Hua Xue, Hao Li, Wenrong Huang, Hebing Zhou, Jingnan Sun, Liping Su, Yanping Ma, Huang Hongming, Hongmei Jing, Zhenling Li, Guangyu Ma, Guohong Su, Jihao Zhou, Biyun Chen, LI Bao, Zhihua Zhang, Lin Yang, Haiping Yang, Yanhong Zhao, Chunyan Sun, Qingming Wang, Qimuge Saiyin, Da Gao, Xiaoxia Chu, Zhenfang Xi, Weiwei Tian, Xuliang Shen, Shi Minxia, Jin Zhang, Yi Chen, Jingbo Xu, Yao Liu, Hongling Peng, Weijun Fu, Jun Luo, Zhenyu Li, Hui-Han Wang, Xiaobo Wang, Xiuli Sun, Jinqiao Zhang, Wei WANG, Yan Yan, Yafei Wang, Xin Du, Yonghuai Feng, Yi Wang, Ying Sun, Liye Zhong, Li Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2023-180736
Published: 2023
Journal Articles

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Hong-Xiao Han, Long Chang, Min Lang, Lin He, Jian Li, Minghui Duan, Daobin Zhou, Xinxin Cao, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1165.
https://doi.org/10.1182/blood-2023-178177
Published: 2023
Journal Articles

Lenalidomide and Dexamethasone for Patients with Rosai-Dorfman Disease: A Single Arm, Single Center, Prospective Phase 2 Study

Long Chang, Lin He, Jian Li, Daobin Zhou, Xinxin Cao, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6331.
https://doi.org/10.1182/blood-2023-184621
Published: 2023
Journal Articles

Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Yuan Jian, Long Chang, Mingxia Shi, Ying Sun, Xiaoxia Chu, Hua Xue, Wenrong Huang, Xuliang Shen, Jie Ma, Guorong Jia, Yaqing Feng, Zhenfang Xi, Yanhong Zhao, Yanping Ma, Jing Xiao, Guangyu Ma, Qingming Wang, Li Bao, Yujun Dong, Hebing Zhou, Chunyan Sun, Guohong Su, Yan Yan, Saiyin Qimuge, Liping Su, Jingnan Sun, Weiwei Tian, Xiuli Sun, Hongmei Jing, Da Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2022) 140 (Supplement 1): 10167–10169.
https://doi.org/10.1182/blood-2022-159361
Published: 2022
Journal Articles

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Ya-Juan Gao, Kaini Shen, Long Chang, Jun Feng, Yueying Mao, Lu Zhang, Xinxin Cao, Daobin Zhou, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 4391–4392.
https://doi.org/10.1182/blood-2022-157044
Published: 2022
Journal Articles

Efficacy and Safety of Peginterferon Alfa-2b in 95 Patients with Myeloproliferative Neoplasms:a Single Center Retrospective Analysis

Long Chang, Hao Cai, Xinxin Cao, Jian Li, Daobin Zhou, Minghui Duan
Journal: Blood
Blood (2022) 140 (Supplement 1): 12244.
https://doi.org/10.1182/blood-2022-168360
Published: 2022